India, 1st August 2025: Altimetrik, a pure-play AI-First, Data and Digital business services company, has been recognised as a Major Contender in Everest Group’s Life Sciences Digital Services PEAK Matrix® Assessment 2025. This recognition reflects the company’s AI-First approach, continued investment in cutting-edge technologies, strategic partnerships and a client-centric approach that drives innovation across the life sciences value chain.
The Everest Group report highlights Altimetrik’s strong portfolio of digital services tailored for pharmaceutical and MedTech clients. Through the expert use of AI, data engineering, data science, machine learning, cloud solutions and DevSecOps, Altimetrik is helping life sciences organisations accelerate drug discovery, optimise clinical trials and improve patient outcomes.
Key strengths of Altimetrik noted in the report include:
- A comprehensive digital portfolio spanning the full life sciences value chain, including predictive insight centres and clinical data migration solutions.
- Strategic collaborations with cloud and technology providers such as Open AI, AWS, Azure, Salesforce and Google Cloud to build industry-specific solutions.
- Proven client impact through innovative case studies such as a connected health platform that reduced patient readmissions by 47% and increased physician productivity by 11%.
- Frameworks and proprietary accelerators that support agile development, real-world evidence integration and adaptive clinical trial design.
Raj Sundaresan, CEO of Altimetrik said: “This recognition reflects our AI-First vision of digitally transforming the pharma and life sciences landscape accelerating drug discovery, optimising clinical trials and improving patient outcomes. Through our Alti LabTM, strategic partnerships like Open AI and capability centres, we’ve built a differentiated service model grounded in agility, innovation and deep domain expertise.”
“In an industry where accelerating innovation, improving patient outcomes and navigating regulatory complexities are critical, our AI-First approach focuses on delivering digital business outcomes built on a solid data foundation.” said Ramji Vasudevan, Head of Life Sciences at Altimetrik. “By working in bite-sized, iterative steps, grounded in deep pharma domain expertise, we help enterprises unlock measurable value through outcomes that are relevant, scalable and impactful.”
Durga Ambati, Practice Director – Everest Group quoted: “Altimetrik’s innovation-led approach, powered by its Centres of Excellence, GenAI-focused labs, strategic partnerships with hyperscalers and data platforms, as well as strong client recognition for agility and responsiveness, has helped it secure a Major Contender position in Everest Group’s Life Sciences Digital Services PEAK Matrix® Assessment 2025.”
Altimetrik’s investments in global talent, leadership expansion and ecosystem partnerships have further enabled the company to deliver scalable, future-ready solutions. The report also notes Altimetrik’s expanding presence in Europe and APAC, as well as its strategic backing through an investment by TPG Capital to accelerate growth.
The PEAK Matrix® is a proprietary framework by Everest Group that evaluates service providers based on their market impact, vision and capability in delivering digital transformation across the life sciences industry.